Princeton, NJ, United States of America

Praveen Aanur

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Praveen Aanur. Retrieved from https://idiyas.com/inventor/praveen-aanur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Praveen Aanur - Innovator in Therapeutic Antibodies

Introduction

Praveen Aanur is an inventor based in Windsor, NJ (US). He is currently employed at Bristol-Myers Squibb Company, where he focuses on the development of innovative therapeutic solutions. Although he has not yet been granted any patents, his work in the field of antibodies shows great promise for future advancements.

Latest Patent Applications

Praveen Aanur's notable patent application is titled "Antibodies Against OX40 and Uses Thereof." This application provides antibodies, or antigen-binding portions thereof, that specifically bind to OX40. The application also outlines the therapeutic uses of these proteins, particularly in the treatment of cancer. Additionally, it includes details about the cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising these polynucleotides.

Conclusion

Praveen Aanur is an emerging inventor in the field of therapeutic antibodies, with a focus on innovative applications for cancer treatment. His contributions to the field, although not yet reflected in granted patents, hold significant potential for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…